Broker Recommendations

Shore Capital hails improved US biotech funding environment for hVIVO

By Benjamin Chiou

Date: Friday 12 Dec 2025

(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
"The funding environment for biotech has been at a lull relative to the...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page